Dr. Reddy’s Laboratories Limited : Dr. Reddy’s Revenues Cross $2 Billion Milestone* in FY12 – 4-traders (press release)

Growth was largely driven by new product launches of ziprasidone, fondaparinux, amoxicillin clavulanic acid, products from Shreveport facility and market share expansion in existing products of lansoprazole and omeprazole Mg OTC. 16 new products were …

Leave a Reply

Your email address will not be published. Required fields are marked *